Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Drugs and US Patents for Sagent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 203608-001 | May 11, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 203608-002 | May 11, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 216542-002 | Feb 17, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201836-001 | Nov 6, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-002 | Jul 18, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | GLYDO | lidocaine hydrochloride | JELLY;TOPICAL | 201094-001 | Apr 28, 2014 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-002 | Dec 29, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.